EV/EBITDA:
-2.24-0.02(-0.90%)Summary
- As of today (August 17, 2025), NTLA EV/EBITDA is -2.24, with a fall of -0.02 (-0.90%) during the most recent trading session on August 15, 2025.
- Over the past year, NTLA EV/EBITDA has increased by +2.23 (+49.89%).
- NTLA EV/EBITDA is now -127.35% below its all-time high of 8.19.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.9% | +0.9% | +0.8% |
| 1 m1 month | +2.6% | -2.5% | -4.3% |
| 3 m3 months | -43.6% | +35.9% | +36.1% |
| 6 m6 months | -4.2% | -0.2% | +2.7% |
| ytdytd | +3.0% | -7.0% | -5.8% |
| 1 y1 year | +49.9% | -51.0% | -52.0% |
| 5 y5 years | +68.9% | +35.7% | -44.8% |
NTLA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.19 | -2.3% | -2.88 | +22.2% |
| 3 m | 3-month | -1.33 | -68.4% | -2.88 | +22.2% |
| 6 m | 6-month | -1.21 | -85.1% | -2.88 | +22.2% |
| 1 y | 1-year | -1.21 | -85.1% | -4.62 | +51.5% |
| 3 y | 3-year | -1.21 | -85.1% | -13.24 | +83.1% |
| 5 y | 5-year | -1.21 | -85.1% | -72.04 | +96.9% |
| alltime | all time | 8.19 | -127.3% | -72.04 | +96.9% |
NTLA EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.24(-3.0%) |
| 2024 | -2.31(-57.1%) |
| 2023 | -5.38(-8.3%) |
| 2022 | -5.87(-82.5%) |
| 2021 | -33.56(+25.6%) |
| Date | Value |
|---|---|
| 2020 | -26.73(+286.3%) |
| 2019 | -6.92(+7.1%) |
| 2018 | -6.46(-9.3%) |
| 2017 | -7.12(+11.1%) |
| 2016 | -6.41 |
FAQ
- What is Intellia Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Intellia Therapeutics, Inc.?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Intellia Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of NTLA is -2.24
What is the all time high EV/EBITDA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high EV/EBITDA is 8.19
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics, Inc. EV/EBITDA has changed by +0.07 (+3.03%) since the beginning of the year
What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +2.23 (+49.89%)